Get started
Author

Matti Kivikko

Levosimendan vs Dobutamine for Patients With Acute Decompensated Heart Failure
2007 · Alexandre Mebazaa, Markku S. Nieminen, et al. · JAMA · 993
Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure
2012 · M. Nikolaou, J. Parissis, et al. · European Heart Journal · 333
Levosimendan: Molecular mechanisms and clinical implications
2011 · Zoltán Papp, István Édes, et al. · International Journal of Cardiology · 324
Sustained Hemodynamic Effects of Intravenous Levosimendan
2003 · Matti Kivikko, Lasse Lehtonen, et al. · Circulation · 256
Pharmacokinetics of levosimendan and its metabolites during and after a 24-hour continuous infusion in patients with severe heart failure
2002 · M. Kivikko, S. Antila, et al. · International Journal of Clinical Pharmacology and Therapeutics · 196
The patient perspective: Quality of life in advanced heart failure with frequent hospitalisations
2015 · Markku S. Nieminen, Kenneth Dickstein, et al. · International Journal of Cardiology · 171
Levosimendan: current data, clinical use and future development.
2013 · M S Nieminen, S Fruhwald, et al. · Europe PMC (PubMed Central) · 153
Duration of the Haemodynamic Action of a 24-h Infusion of Levosimendan in Patients with Congestive Heart Failure
2006 · J. Lilleberg, M. Laine, et al. · European Journal of Heart Failure · 142
Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paper
2016 · Dimitrios Farmakis, Julian Alvarez, et al. · International Journal of Cardiology · 141
PDF
Levosimendan Facilitates Weaning From Cardiopulmonary Bypass in Patients Undergoing Coronary Artery Bypass Grafting With Impaired Left Ventricular Function
2009 · Heidi I. Eriksson, Jouko R. Jalonen, et al. · The Annals of Thoracic Surgery · 131
PDF
Pharmacodynamics and Safety of a New Calcium Sensitizer, Levosimendan, and Its Metabolites during an Extended Infusion in Patients with Severe Heart Failure
2002 · Matti Kivikko, Saila Antila, et al. · The Journal of Clinical Pharmacology · 131
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use
2020 · Zoltán Papp, Piergiuseppe Agostoni, et al. · Journal of Cardiovascular Pharmacology · 114
Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion
2015 · W. Toller, M. Heringlake, et al. · International Journal of Cardiology · 109
Levosimendan meta-analyses: Is there a pattern in the effect on mortality?
2016 · P. Pollesello, J. Parissis, et al. · International Journal of Cardiology · 91
Intravenous Levosimendan vs. Dobutamine in Acute Decompensated Heart Failure Patients on Beta-Blockers
2010 · Claes-Håkan Bergh, Bert Andersson, et al. · European Journal of Heart Failure · 89
The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinion
2016 · Markku S. Nieminen, Michael Buerke, et al. · International Journal of Cardiology · 83
Repetitive Dosing of Intravenous Levosimendan Improves Pulmonary Hemodynamics in Patients With Pulmonary Hypertension: Results of a Pilot Study
2008 · Franz X. Kleber, Tom Bollmann, et al. · The Journal of Clinical Pharmacology · 83
Renal Effects of Levosimendan: A Consensus Report
2013 · Mehmet B. Yilmaz, Elena Grossini, et al. · Cardiovascular Drugs and Therapy · 78
PDF
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use
2020 · Zoltán Papp, Piergiuseppe Agostoni, et al. · Cardiac failure review · 73
PDF
Use of Levosimendan in Cardiac Surgery: An Update After the LEVO-CTS, CHEETAH, and LICORN Trials in the Light of Clinical Practice
2017 · Fabio Guarracino, Matthias Heringlake, et al. · Journal of Cardiovascular Pharmacology · 73
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus
2019 · Dimitrios Farmakis, Piergiuseppe Agostoni, et al. · International Journal of Cardiology · 69
Pharmacokinetics of levosimendan and its circulating metabolites in patients with heart failure after an extended continuous infusion of levosimendan
2004 · Saila Antila, Matti Kivikko, et al. · British Journal of Clinical Pharmacology · 69
PDF
Repetitive use of levosimendan for treatment of chronic advanced heart failure: Clinical evidence, practical considerations, and perspectives: An expert panel consensus
2014 · M.S. Nieminen, J. Altenberger, et al. · International Journal of Cardiology · 66
PDF
Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application
2018 · S. Bouchez, F. Fedele, et al. · Cardiovascular Drugs and Therapy · 63
PDF
Beneficial association of β-blocker therapy on recovery from severe acute heart failure treatment: Data from the Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support trial*
2011 · Michael Böhm, Andreas Link, et al. · Critical Care Medicine · 63
Works count: 63
Citation count: 4,552
H-index: 31
I10-index: 41
Year
Topic
Type